Evidence map›Paper›PMID 41685115›Full record

ArticleJAAD case reports2026

A rare presentation of Merkel cell carcinoma in a young immunocompetent woman.

Fatimatou Saka, Aarthi Kannan, Bhaba Das, Michael P O'Leary, Louis A Fanucci, Mark Chambers, Nils Lambrecht, Ling Gao

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fatimatou SakaCharles R. Drew University of Medicine and Science, Los Angeles, California.
Aarthi KannanSouthern California Institute for Research and Education, Long Beach, California.
Bhaba DasSouthern California Institute for Research and Education, Long Beach, California.
Michael P O'LearyDivision of Surgical Oncology, School of Medicine, University of California-Irvine, Irvine, California.
Louis A FanucciDiagnostic & Molecular Medicine, Tibor Rubin VA Medical Center, VA Long Beach Healthcare System, Long Beach, California.
Mark ChambersDiagnostic & Molecular Medicine, Tibor Rubin VA Medical Center, VA Long Beach Healthcare System, Long Beach, California.
Nils LambrechtPathology and Laboratory Medicine, Tibor Rubin VA Medical Center, VA Long Beach Healthcare System, Long Beach, California.
Ling GaoSouthern California Institute for Research and Education, Long Beach, California.

Funding

Identifying novel therapies targeting Merkel cell carcinoma and tumor microenvironmentR01CA266514 · NCI · SOUTHERN CALIFORNIA INST FOR RES/EDUC · PI Ling Gao · 2022 to 2026
$1.7M
BLRD VA I01 BX004841CSRD VA I01 CX002497NCI NIH HHS R01 CA266514
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

early-onset Merkel cell carcinomaMerkel cell carcinomaovarian metastasisrare metastatic sitesunknown primary tumor

Identifiers

PMID41685115
PMCPMC12890804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.